Jeremy B. Hayden - 25 Nov 2025 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Reporting relationship: Chief Legal Officer
Issuer ticker: SGHT
Reported as of: 25 Nov 2025
Net transaction value: -$274,482
SEC form: 4
Accepted by SEC: 26 Nov 2025, 18:52:36 UTC
Prior SEC filing: 14 Nov 2025
Next SEC filing: 06 Jan 2026
Source filing: View source filing
Reporting owner signature: Jeremy Hayden

Key filing fact

Jeremy B. Hayden filed Form 4 for Sight Sciences, Inc. (SGHT) on 26 Nov 2025.

Key facts

This page summarizes Jeremy B. Hayden's Form 4 filing for Sight Sciences, Inc. (SGHT).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 26 Nov 2025, 18:52.

Change

Previous filing in this sequence was filed on 14 Nov 2025.
Current net transaction value: -$274,482.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001650737 Primary reporting owner

HAYDEN JEREMY B.

Relationship: Chief Legal Officer
Address: C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK
Signature: Jeremy Hayden
Signature date: 26 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGHT transaction

Common Stock

Options Exercise

Transaction value: $73,618
Shares: +37,560
Change %: +15%
Price: $1.96
Shares after: 294,150
Date: 25 Nov 2025
Ownership: Direct
Footnotes: F1, F2

SGHT transaction

Common Stock

Options Exercise

Transaction value: $14,288
Shares: +7,290
Change %: +2.5%
Price: $1.96
Shares after: 301,440
Date: 25 Nov 2025
Ownership: Direct
Footnotes: F1, F2

SGHT transaction

Common Stock

Sale

Transaction value: $362,388
Shares: -44,850
Change %: -15%
Price: $8.08
Shares after: 256,590
Date: 25 Nov 2025
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SGHT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -37,560
Change %: -48%
Price: $0.000000
Shares after: 40,000
Date: 25 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 37,560
Exercise price: $1.96
Footnotes: F1, F4

SGHT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -7,290
Change %: -48%
Price: $0.000000
Shares after: 8,000
Date: 25 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,290
Exercise price: $1.96
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with, and pursuant to, the terms of a marital separation agreement previously entered into between the Reporting Person and his former spouse. The Reporting Person's spouse will receive all proceeds from the shares sold in the transactions.

Footnote F2

Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan.

Footnote F3

Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The options are fully vested and exercisable.